 |
|
|
|||||
While Silicon Valley argues over bubbles, benchmarks, and who has the smartest model, Anthropic has been focused on solving problems that rarely generate hype but ultimately determine adoption: whether AI can be trusted to operate inside the worlds most sensitive systems. Known for its safety-first posture and the Claude family of large language models (LLMs), Anthropic is placing its biggest strategic bets where AI optimism tends to collapse fastest, i.e., regulated industries. Rather than framing Claude as a consumer product, the company has positioned its models as core enterprise infrastructuresoftware expected to run for hours, sometimes days, inside healthcare systems, insurance platforms, and regulatory pipelines. Trust is what unlocks deployment at scale, Daniela Amodei, Anthropic cofounder and president, tells Fast Company in an exclusive interview. In regulated industries, the question isnt just which model is smartestits which model you can actually rely on, and whether the company behind it will be a responsible long-term partner. That philosophy took concrete form on January 11, when Anthropic launched Claude for Healthcare and Life Sciences. The release expanded earlier life sciences tools designed for clinical trials, adding support for such requirements as HIPAA-ready infrastructure and human-in-the-loop escalation, making its models better suited to regulated workflows involving protected health information. We go where the work is hard and the stakes are real, Amodei says. What excites us is augmenting expertisea clinician thinking through a difficult case, a researcher stress-testing a hypothesis. Those are moments where a thoughtful AI partner can genuinely accelerate the work. But that only works if the model understands nuance, not just pattern matches on surface-level inputs. That same thinking carried into Cowork, a new agentic AI capability released by Anthropic on January 12. Designed for general knowledge workers and usable without coding expertise, Claude Cowork can autonomously perform multistep tasks on a users computerorganizing files, generating expense reports from receipt images, or drafting documents from scattered notes. According to reports, the launch unintentionally intensified market and investor anxiety around the durability of software-as-a-service businesses; many began questioning the resilience of recurring software revenue in a world where general-purpose AI agents can generate bespoke tools on demand. Anthropics most viral product, Claude Code, has amplified that unease. The agentic tool can help write, debug, and manage code faster using natural-language prompts, and has had a substantial impact among engineers and hobbyists. Users report building everything from custom MRI viewers to automation systems entirely with Claude. Over the past three years, the companys run-rate revenue has grown from $87 million at the end of 2023 to just under $1 billion by the end of 2024 and to $9 billion-plus by the end of 2025. That growth reflects enterprises, startups, developers, and power users integrating Claude more deeply into how they actually work. And we’ve done this with a fraction of the compute our competitors have, Amodei says. Building for Trust in the Most Demanding Enterprise Environments According to a mid-2025 report by venture capital firm Menlo Ventures, AI spending across healthcare reached $1.4 billion in 2025, nearly tripling the total from 2024. The report also found that healthcare organizations are adopting AI 2.2 times faster than the broader economy. The largest spending categories include ambient clinical documentation, which accounted for $600 million, and coding and billing automation, at $450 million. The fastest-growing segments, however, reflect where operational pressure is most acute, like patient engagement, where spending is up 20 times year over year, and prior authorization, which grew 10 times over the same period. Claude for Healthcare is being embedded directly into the latters workflows, attempting to take on time-consuming and error-prone tasks such as claims review, care coordination, and regulatory documentation. Claude for Life Sciences has followed a similar pattern. Anthropic has expanded integrations with Medidata, ClinicalTrials.gov, Benchling, and bioRxiv, enabling Claude to operate inside clinical trial management and scientific literature synthesis. The company has also introduced agent skills for protocol drafting, bioinformatics pipelines, and regulatory gap analysis. Customers include Novo Nordisk, Banner Health, Sanofi, Stanford Healthcare, and Eli Lilly. According to Anthropic, more than 85% of its 22,000 providers at Banner Health reported working faster with higher accuracy using Claude-assisted workflows. Anthropic also reports that internal teams at Novo Nordisk have reduced clinical documentation timelines from more than 12 weeks to just minutes. Amodei adds that what surprised her most was how quickly practitioners defined their relationship with the companys AI models on their own terms. They’re not handing decisions off to Claude, she says. They’re pulling it into their workflow in really specific wayssynthesizing literature, drafting patient communications, pressure-testing their reasoningand then applying their own judgment. That’s exactly the kind of collaboration we hoped for. But honestly, they got there faster than I expected. Industry experts say the appeal extends beyond raw performance. Anthropics deliberate emphasis on trust, restraint, and long-horizon reliability is emerging as a genuine competitive moat in regulated enterprise sectors. This approach aligns with bounded autonomy and sandboxed execution, which are essential for safe adoption where raw speed often introduces unacceptable risk, says Cobus Greyling, chief evangelist at Kore.ai, a vendor of enterprise AI platforms. He adds that Anthropics universal agent concept introduced a third architectural model for AI agents, expanding how autonomy can be safely deployed. Other AI competitors are also moving aggressively into the healthcare sector, though with different priorities. OpenAI debuted its healthcare offering, ChatGPT Health, in January 2026. The product is aimed primarily at broad consumer and primary care use cases such as symptom triage and health navigation outside clinic hours. It benefits from massive consumer-scale adoption, handling more than 230 million health-related queries globally each week. While GPT Health has proven effective in generalist tasks such as documentation support and patient engagement, Claude is gaining traction in more specialized domains that demand structured reasoning and regulatory rigorincluding drug discovery and clinical trial design. Greyling cautions, however, that slow procurement cycles, entrenched organizational politics, and rigid compliance requirements can delay AI adoption across healthcare, life sciences, and insurance. Even with strong technical performance in models like Claude 4.5, enterprise reality demands extensive validation, custom integrations, and risk-averse stakeholders, he says. The strategy could stall if deployment timelines stretch beyond economic justification or if cost ad latency concerns outweigh reliability gains in production. In January, Travelers announced it would deploy Claude AI assistants and Claude Code to nearly 10,000 engineers, analysts, and product ownersone of the largest enterprise AI rollouts in insurance to date. Each assistant is personalized to employee roles and connected to internal data and tools in real time. Likewise, Snowflake committed $200 million to joint development. Salesforce integrated Claude into regulated-industry workflows, while Accenture expanded multiyear agreements to scale enterprise deployments. AI Bubble or Inflection Point? Skeptics argue that todays agent hype resembles past automation cyclesbig promises followed by slow institutional uptake. If valuations reflect speculation rather than substance, regulated industries should expose weaknesses quickly, and Anthropic appears willing to accept that test. Its capital posture reflects confidence, through a $13 billion Series F at a $183 billion valuation in 2025, followed by reports of a significantly larger round under discussion. Anthropic is betting that the AI race will ultimately favor those who design for trust and responsibility first. We built a company where research, product, and policy are integratedthe people building our models work deeply with the people studying how to make them safer. That lets us move fast without cutting corners, Amodei says. Countless industries are putting Claude at the center of their most critical work. That trust doesn’t happen unless you’ve earned it.
Category:
E-Commerce
Many people spend an incredible amount of time worrying about how to be more successful in life. But what if thats the wrong question? What if the real struggle for lots of us isnt how to be successful, but how to actually feel successful? Thats the issue lots of strivers truly face, according to ex-Googler turned neuroscientist and author Anne-Laure Le Cunff. In her book Tiny Experiments, she explores how to get off the treadmill of constantly chasing the next milestone, and instead find joy in the process of growth and uncertainty. Youre probably doing better than you give yourself credit for, she explained on LinkedIn recently, before offering 10 telltale signs that what you need isnt to achieve more but to recognize your achievements more. Are you suffering from success dysmorphia? Before we get to those signs, let me try to convince you that youre probably being way too hard on yourself about how well youre doing in life. Start by considering the concept of dysmorphia. Youve probably heard the term in relation to eating disorders. In that context, dysmorphia is when you have a distorted picture of your body. You see a much larger person in the mirror than the rest of the world sees when they look at you. But dysmorphia doesnt just occur in relation to appearance. One recent poll found that 29% of Americans (and more than 40% of young people) experience money dysmorphia. That is, even though theyre doing objectively okay financially, they constantly feel as if theyre falling behind. Financial experts agree that thanks to a firehose of unrealistic images and often dubious money advice online, its increasingly common for people to have a distorted sense of how well theyre actually doing when it comes to money. Or take the idea of productivity dysmorphia, popularized by author Anna Codrea-Rado. In a widely shared essay, she outed herself as a sufferer, revealing that despite working frantically and fruitfully, she never feels that shes done enough. When I write down everything Ive done since the beginning of the pandemicpitched and published a book, launched a media awards, hosted two podcastsI feel overwhelmed. The only thing more overwhelming is that I feel like Ive done nothing at all, she wrote back in 2021. Which means she did all that in just over a year and still feels inadequate. Thats crazy. But its not uncommon to drive ourselves so relentlessly. In Harvard Business Review, Jennifer Moss, author of The Burnout Epidemic, cites a Slack report showing that half of all desk workers say they rarely or never take breaks during the workday. She calls this kind of toxic productivity, a common sentiment in todays work culture. 10 signs of success All together, this evidence paints a picture of a nation that is pretty terrible at gauging and celebrating success. The roots of the issue obviously run deep in our culture and economy. Reorienting our collective life to help us all recognize that there is such a thing as enough is beyond the scope of this column. But in the meantime, neuroscience can help you take a small step toward greater mental peace by reminding you youre probably doing better than you sometimes feel you are. Especially, Le Cunff stresses, if you notice these signs of maturity, growth, and balance in your life. You celebrate small wins. You try again after failing. You pause before reacting. You take breaks without guilt. You recover from setbacks faster. You ask for help when you need it. Youre kind to yourself when you make mistakes. You notice patterns instead of judging them. You make decisions based on values, not pressure. Youre more curious than anxious about whats next. A neuroscientist and a writer agree: Practice becoming Writer Kurt Vonnegut once advised a young correspondent, Practice any art, music, singing, dancing, acting, drawing, painting, sculpting, poetry, fiction, essays, reportage, no matter how well or badly, not to get money and fame, but to experience becoming, to find out whats inside you, to make your soul grow. In other words, artists agree with neuroscientists. Were all works in progress. Youre always going to be in the middle of becoming who you are. You may as well learn to appreciate yourself and the process along the way. We often feel like we need to reach just one more milestone before we can feel successful. But the tme to celebrate isnt when youre arrived at successnone of us fully ever gets thereits at every moment of growth and wisdom along the journey. By Jessica Stillman This article originally appeared in Fast Company‘s sister publication, Inc. Inc. is the voice of the American entrepreneur. We inspire, inform, and document the most fascinating people in business: the risk-takers, the innovators, and the ultra-driven go-getters that represent the most dynamic force in the American economy.
Category:
E-Commerce
January arrives with a familiar hangover. Too much food. Too much drink. Too much screen time. And suddenly social media is full of green juices, charcoal supplements, foot patches, and seven-day liver resets, all promising to purge the body of mysterious toxins and return it to a purer state. In the first episode of Strange Health, a new visualized podcast from The Conversation, hosts Katie Edwards and Dr. Dan Baumgardt put detox culture under the microscope and ask a simple question: Do we actually need to detox at all? Strange Health explores the weird, surprising, and sometimes alarming things our bodies do. Each episode takes a popular health or wellness trend, viral claim, or bodily mystery and examines what the evidence really says, with help from researchers who study this stuff for a living. Edwards, a health and medicine editor at The Conversation, and Baumgardt, a general practicioner and lecturer in health and life sciences at the University of Bristol, share a long-standing fascination with the bodys improbabilities and limits, plus a healthy skepticism for claims that sound too good to be true. This opening episode dives straight into detoxing. From juice cleanses and detox teas to charcoal pills, foot pads, and coffee enemas, Edwards and Baumgardt watch, wince, and occasionally laugh their way through some of the internets most popular detox trends. Along the way, they ask what these products claim to remove, how they supposedly work, and why feeling worse is often reframed online as a sign that a detox is working. The episode also features an interview with Trish Lalor, a liver expert from the University of Birmingham, whose message is refreshingly blunt. Your body is really set up to do it by itself, she explains. The liver, working alongside the kidneys and gut, already detoxifies the body around the clock. For most healthy people, Lalor says, there is no need for extreme interventions or pricey supplements. That does not mean everything labeled detox is harmless. Lalor explains where certain ingredients can help, where they make little difference, and where they can cause real damage if misused. Real detoxing looks less like a sachet or a foot patch and more like hydration, fiber, rest, moderation, and giving your liver time to do the job it already does remarkably well. If youre buying detox patches and supplements, then its probably your wallet that is about to be cleansed, not your liver. Strange Health is hosted by Katie Edwards and Dan Baumgardt. The executive producer is Gemma Ware, with video and sound editing by Sikander Khan. Artwork by Alice Mason. Edwards and Baumgardt talk about two social media clips in this episode, one from 30.forever on TikTok and one from velvelle_store on Instagram. Listen to Strange Health via any of the apps listed above, download it directly via our RSS feed, or find out how else to listen here. A transcript is available via the Apple Podcasts or Spotify apps. Katie Edwards is a commissioning editor for health and medicine and host of the Strange Health podcast at The Conversation. Dan Baumgardt is a senior lecturer at the School of Psychology and Neuroscience at the University of Bristol. This article is republished from The Conversation under a Creative Commons license. Read the original article.
Category:
E-Commerce
All news |
||||||||||||||||||
|
||||||||||||||||||